Alec Stranahan
Stock Analyst
(n/a)
# 4,648
Out of 4,648 analysts
23
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:
Stocks Rated by Alec Stranahan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DAWN Day One Biopharmaceuticals | Upgrades: Buy | $11 → $24 | $14.81 | +62.05% | 3 | Aug 1, 2024 | |
| CATX Perspective Therapeutics | Initiates: Buy | $24 | $12.19 | +96.88% | 1 | Jul 25, 2024 | |
| RVMD Revolution Medicines | Maintains: Buy | $48 → $55 | $55.87 | -1.56% | 3 | Jul 16, 2024 | |
| NVAX Novavax | Maintains: Neutral | $12 → $18 | $9.12 | +97.37% | 3 | Jun 14, 2024 | |
| ERAS Erasca | Downgrades: Neutral | $11 → $6 | $2.87 | +109.06% | 1 | Jan 5, 2024 | |
| KRYS Krystal Biotech | Maintains: Buy | $118 → $140 | $170.85 | -18.06% | 3 | May 25, 2023 | |
| XNCR Xencor | Initiates: Buy | $42 | $21.52 | +95.17% | 1 | May 19, 2023 | |
| YMAB Y-mAbs Therapeutics | Maintains: Neutral | $6 → $12 | $14.87 | -19.30% | 4 | May 15, 2023 | |
| TGTX TG Therapeutics | Maintains: Underperform | $5 → $6 | $24.36 | -75.37% | 2 | Dec 29, 2022 | |
| HOOK HOOKIPA Pharma | Downgrades: Underperform | $60 → $5 | $3.76 | +32.98% | 1 | Dec 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $45 | $30.94 | +45.44% | 1 | Dec 1, 2022 |
Day One Biopharmaceuticals
Aug 1, 2024
Upgrades: Buy
Price Target: $11 → $24
Current: $14.81
Upside: +62.05%
Perspective Therapeutics
Jul 25, 2024
Initiates: Buy
Price Target: $24
Current: $12.19
Upside: +96.88%
Revolution Medicines
Jul 16, 2024
Maintains: Buy
Price Target: $48 → $55
Current: $55.87
Upside: -1.56%
Novavax
Jun 14, 2024
Maintains: Neutral
Price Target: $12 → $18
Current: $9.12
Upside: +97.37%
Erasca
Jan 5, 2024
Downgrades: Neutral
Price Target: $11 → $6
Current: $2.87
Upside: +109.06%
Krystal Biotech
May 25, 2023
Maintains: Buy
Price Target: $118 → $140
Current: $170.85
Upside: -18.06%
Xencor
May 19, 2023
Initiates: Buy
Price Target: $42
Current: $21.52
Upside: +95.17%
Y-mAbs Therapeutics
May 15, 2023
Maintains: Neutral
Price Target: $6 → $12
Current: $14.87
Upside: -19.30%
TG Therapeutics
Dec 29, 2022
Maintains: Underperform
Price Target: $5 → $6
Current: $24.36
Upside: -75.37%
HOOKIPA Pharma
Dec 2, 2022
Downgrades: Underperform
Price Target: $60 → $5
Current: $3.76
Upside: +32.98%
Dec 1, 2022
Initiates: Buy
Price Target: $45
Current: $30.94
Upside: +45.44%